🇺🇸 FDA
Patent

US 7504231

Method of alleviating chronic pain via peripheral inhibition of neurotransmitter synthesis

granted A61KA61K31/00A61K31/198

Quick answer

US patent 7504231 (Method of alleviating chronic pain via peripheral inhibition of neurotransmitter synthesis) held by The Board of Regents of the University of Oklahoma expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/00, A61K31/198, A61K31/20, A61K31/35